John E. Eriksson,Preethy Paul,Emilia Peuhu,M. A. Akbarsha
申请号：
US14827343
公开号：
US09623002B2
申请日:
2015.08.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
